Asthma Clinical Trials in Chicago

Showing 61-80 of 365 trials

Technology-Enhanced Asthma Care in Children at Clinic and Home Study

NCT06820593

A randomized controlled trial with parent-child pairs of children with persistent or uncontrolled asthma. An intervention group (n=40 parent-child pairs) will receive the mobile health (mHealth) app and digital sensors with enhanced support from a population health manager role, hereinafter referred to as an asthma coordinator, to provide remote patient monitoring (RPM). A comparison group (n=40 parent-child pairs) will receive the mHealth app and sensors without RPM support to silently collect inhaler use information without mHealth app features. The focus of this project is to evaluate the feasibility and acceptability of delivering a digital intervention for pediatric asthma with RPM in the outpatient setting.

Asthma in ChildrenChronic Diseases in Children

Ann & Robert H Lurie Children's Hospital of Chicago80 participantsStarted Mar 2025

Chicago, Illinois, United States

Active Not RecruitingPhase 32.2 miles

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

NCT05748600

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to evaluate improvements in lung function, asthma control, and quality of life. In addition, the study will further evaluate the safety and tolerability of dexpramipexole in participants with eosinophilic asthma.

Eosinophilic AsthmaAsthma; EosinophilicAsthma Attack

Areteia Therapeutics600 participantsStarted Jan 2023

Chandler, Arizona, United States • Peoria, Arizona, United States • Surprise, Arizona, United States +332 more locations

Technology-Enhanced Asthma Care in Children at Clinic and Home Study

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

Asthma Trials in Other Cities

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Prophylactic Minimally Invasive Surfactant Evaluation

A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome

Severe Asthma Research Program

A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults

Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

ARrest RESpiraTory Failure From PNEUMONIA

Effect of Ketamine and Etomidate During RSI on Long Term Outcomes

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

Multicenter HomeVENT: Home Values and Experiences Navigation Track

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Other Conditions in Chicago